- Filed
- May 8, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Apr 30, 2025 | 45.56M sh |
| Short Term Investments | Q2 2025 · Mar 31, 2025 | $31.47M |
| Short Term Investments | Q2 2025 · Sep 30, 2024 | $36.88M |
| Cash And Equivalents | Q2 2025 · Mar 31, 2025 | $104.7M |
| Cash And Equivalents | Q2 2025 · Sep 30, 2024 | $93.46M |
| Current Liabilities | Q2 2025 · Mar 31, 2025 | $195.56M |
| Current Liabilities | Q2 2025 · Sep 30, 2024 | $42.15M |
| Total Liabilities | Q2 2025 · Mar 31, 2025 | $205.13M |
| Total Liabilities | Q2 2025 · Sep 30, 2024 | $198.95M |
| Current Assets | Q2 2025 · Mar 31, 2025 | $203.91M |
| Current Assets | Q2 2025 · Sep 30, 2024 | $185.05M |
| Total Assets | Q2 2025 · Mar 31, 2025 | $425.34M |
| Total Assets | Q2 2025 · Sep 30, 2024 | $413.75M |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 48.04M sh |
| Shares Diluted | Q2 2025 · Mar 31, 2024 | 46.59M sh |
| Stock Repurchased | Q2 2025 · Mar 31, 2024 | $0 |
| Capex | Q2 2025 · Mar 31, 2024 | $724K |
| Operating Cash Flow | Q2 2025 · Mar 31, 2024 | −$2.4M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | $216.15M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | $213.8M |
| Stockholders Equity | Q2 2025 · Sep 30, 2023 | $205.19M |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | $0.01 |
| Eps Diluted | Q2 2025 · Mar 31, 2024 | −$0.12 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | $0.01 |
| Eps Basic | Q2 2025 · Mar 31, 2024 | −$0.12 |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $14.94M |
| Sga Expense | Q2 2025 · Mar 31, 2024 | $30.48M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $9.71M |
| Rd Expense | Q2 2025 · Mar 31, 2024 | $18.59M |
| Net Income | Q2 2025 · Mar 31, 2024 | $282K |
| Net Income | Q2 2025 · Mar 31, 2024 | −$5.51M |
| Operating Income | Q2 2025 · Mar 31, 2024 | $698K |
| Operating Income | Q2 2025 · Mar 31, 2024 | −$6.22M |
| Revenue | Q2 2025 · Mar 31, 2024 | $46.97M |
| Revenue | Q2 2025 · Mar 31, 2024 | $83.89M |